- PR Newswire•6 days agoJazz Pharmaceuticals to Report 2016 Fourth Quarter and Full Year Financial Results on February 28, 2017
DUBLIN, Feb. 14, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 fourth quarter and full year financial results on Tuesday, February 28, 2017, ...
- Motley Fool•6 days ago
Why AbbVie, Celgene, and Jazz Pharmaceuticals look like biotech bargains you can buy right now.
- Zacks•11 days ago
Medical is one of the few sectors that has consistently recorded earnings growth over the last 4 quarters. Here is a look at 5 pharma and biotech stocks that look set to beat Q4 earnings estimates.
JAZZ : Summary for Jazz Pharmaceuticals plc - Ordi - Yahoo Finance
Jazz Pharmaceuticals Public Limited Company (JAZZ)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||103.07 x 100|
|Ask||150.00 x 100|
|Day's Range||135.39 - 137.54|
|52 Week Range||95.80 - 160.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.99|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|